GSK & Novartis unite
June 21, 2016
Sporting some of the best
known leading household brands in
Panadol, Voltaren, Zovirax, Otrivin,
and Sensodyne, GSK has now
completed the establishment of
a joint venture with Novartis, first
muted in Mar 2015, creating a new
FMCH entity.
An ageing population and the rise
of self-care driven by a growing
interest in health and increased
access to online health information,
all make consumer healthcare
an appealing sector, growing
worldwide at around 4% and 4.6%
in Australia, the company said.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jun 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jun 16